Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

administrators

Private

Posts


  • Implications of updated safety information in Product Monograph
    Jennifer CarrollJ Jennifer Carroll

    Hey @JDilly11

    Hard to provide comments without seeing the updated TMA copy. This question is likely better submitted as an opinion so that we can look at the update and the nature of the claims being made in current or proposed future pieces. As a general guiding principle, the assessment is made by looking at the update in combination with the APS copy to ensure it reflects the same context as the TMA. If there is something that would trigger the inclusion, then it will likely have to be added. Whether both data presentations are required will also depend on the APS copy and the finalized TMA copy.

    Claims & Support/References for Claims

  • New pediatric indication claims
    Jennifer CarrollJ Jennifer Carroll

    Hey @mimi77
    While we don’t provide reviews of the Forum, in general terms the claim should reflect the nature of the update. From our understanding of the description, this would be authorization in a new population (pediatrics) and not a net new indication. As such, claims should reflect “Now authorized for use in pediatric patients for x” or something similar.

    Claims & Support/References for Claims

  • PAAB Code - Post hoc analysis
    Jennifer CarrollJ Jennifer Carroll

    Hello @msargeant

    Apologies for not seeing this question sooner. Per 3.1.1, post-hoc analysis are generally not considered acceptable evidence at this time. The circumstance in which post-hoc analyses would be considered acceptable is outlined in the statement that follows that copy which states “Data included in the TMA may be acceptable”. HTH.

    General Discussion

  • Guideline terminology: Canadian, US/North American, International
    Jennifer CarrollJ Jennifer Carroll

    Hey @HollyMed

    Yes, per the copy "In the scenario described above where guidelines lower in the aforementioned hierarchy are being used over the available US guidelines, evidence must be provided to support that these guidelines are a true reflection of Canadian practice". Note that there may be instances where we ask for more information about US guidelines. This is extremely rare and the rationale is disclosed during the review process. If you find yourself in this rare instance, please reach out to the reviewer for clarification.

    Claims & Support/References for Claims

  • Guideline terminology: Canadian, US/North American, International
    Jennifer CarrollJ Jennifer Carroll

    Hey @HollyMed

    Please see Q&A 593.

    Claims & Support/References for Claims

  • Middle level fair balance linking to high-level fair balance
    Jennifer CarrollJ Jennifer Carroll

    @Jennifer_CM
    Example 3 appears to be about the product monograph web link destination. The original question above is about linking middle level fair balance to highest level fair balance. Linking middle level fair balance to highest requires that it’s within the same tool or directly attached. A print journal ad is not the same medium as a URL link (web based) and therefore would not be acceptable.

    Claims & Support/References for Claims

  • 577 - Hi - I understand that as per Section 6.6iv, an email informing HCPs about 'updated provincial formulary criteria for Drug X' would be considered PAAB exempt (if there were no linkage to therapeutic or promotional claims). Could you provide clarification on whether including a website link to the full formulary list of a province would still be considered exempt? Note that this formulary list contains criteria specific to Drug X.
    Jennifer CarrollJ Jennifer Carroll

    Hey @ALee
    “Indirect link to a general formulary/Provincial homepage” is the same as “full formulary list of a province”. As per the response above, this would not be considered exempt.

    Linkage Issues

  • Guidance on Patient Reported Outcomes
    Jennifer CarrollJ Jennifer Carroll

    Hi tk2022

    Please see our more recent “Guidance on Real World Evidence/Data” for criteria and direction on the presentation of RWE in advertising to health care professionals. Please also see our "Guidance on the use of the Attention Icon" regarding unblinded data.

    Guidance on Code Application

  • Consensus Guidelines
    Jennifer CarrollJ Jennifer Carroll

    Hi @megancouture

    Claims based on acceptable, authoritative consensus guidelines do not need to be verbatim from the reference. However, it must capture the recommendation accurately and within context. It must not impart a new or different meaning than the guidelines.

    PAAB Code

Member List

D devadmin
C chaddock
Glenn GolazG Glenn Golaz
Pauline DongP Pauline Dong
Jennifer CarrollJ Jennifer Carroll
Patrick MassadP Patrick Massad
D dhageman
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups